about
The influence of ezetimibe on classical and alternative activation pathways of monocytes/macrophages isolated from patients with hypercholesterolemia.Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes/macrophages.Time-Dependent Changes in Apoptosis Upon Autophagy Inhibition in Astrocytes Exposed to Oxygen and Glucose Deprivation.Metformin reduces the expression of NADPH oxidase and increases the expression of antioxidative enzymes in human monocytes/macrophages cultured in vitro.SOCS and diabetes--ups and downs of a turbulent relationship.Knockdown of AKT3 (PKBγ) and PI3KCA suppresses cell viability and proliferation and induces the apoptosis of glioblastoma multiforme T98G cells.A peptide nucleic acid (PNA)-mediated polymerase chain reaction clamping allows the selective inhibition of the ERVWE1 gene amplification.A Novel, Highly Selective RT-QPCR Method for Quantification of MSRV Using PNA Clamping Syncytin-1 (ERVWE1)Eplerenone mimics features of the alternative activation in macrophages obtained from patients with heart failure and healthy volunteers.Immunolocalization and expression of kinin B1R and B2R receptors in human inflammatory bowel disease.Eplerenone promotes alternative activation in human monocyte-derived macrophages.AMP-activated protein kinase is involved in induction of protective autophagy in astrocytes exposed to oxygen-glucose deprivation.Exenatide and metformin express their anti-inflammatory effects on human monocytes/macrophages by the attenuation of MAPKs and NFκB signaling.Metformin affects macrophages' phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human monocytes/macrophThe application of strand invasion phenomenon, directed by peptide nucleic acid (PNA) and single-stranded DNA binding protein (SSB) for the recognition of specific sequences of human endogenous retroviral HERV-W family.AMP-activated protein kinase is involved in induction of protective autophagy in astrocytes exposed to oxygen-glucose deprivation.Corrigendum to "Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner" [Pharmacological Reports 68 (2016) 329-337].Sequence analysis of proviral DNA of porcine endogenous retroviruses.Superoxide dismutase 1 and glutathione peroxidase 1 are involved in the protective effect of sulodexide on vascular endothelial cells exposed to oxygen-glucose deprivation.Transforming growth factor-beta1 and its receptors in patients with ulcerative colitis.Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner.Tricyclic Antidepressants Modulate Stressed Mitochondria in Glioblastoma Multiforme CellsGrowth hormone gene polymorphism and reproductive performance of ai bullsExpression and localisation of kinin receptors in colorectal polypsGene expression and activity of antioxidant enzymes in the blood cells of workers who were occupationally exposed to leadTREATMENT WITH CINACALCET INCREASES PLASMA ADIPONECTIN CONCENTRATION IN HEMODIALYZED PATIENTS WITH CHRONIC KIDNEY DISEASE AND SECONDARY HYPERPARATHYROIDISMCorrigendum to "Metformin affects macrophages' phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human mCorrigendum to "Eplerenone promotes alternative activation in human monocyte-derived macrophages" [Pharmacol. Rep. 65 (2013) 226-234]Treatment Based on Cinacalcet Reduces Oxidative Stress in Hemodialysis Patients with Secondary HyperparathyroidismCorrigendum to "Metformin affects macrophages' phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human mCorrigendum to "Eplerenone promotes alternative activation in human monocyte-derived macrophages" [Pharmacol. Rep. 65 (2013) 226-234]Corrigendum to "Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in A protein kinase A and B/Akt manner'' [Pharmacol. Rep. 68 (2016) 329-337]
P50
Q33883204-0423976C-59AA-4B35-8087-0D957603B2C4Q35956905-1A38696E-BA40-4767-BAB9-8738D133C74CQ35959967-1F03A4A1-FEC8-476C-9BCB-0DD9CDABF118Q36640261-F268B109-7A99-48B1-83D2-C38B0F11D382Q38075516-0D3E5FC3-1539-4229-B545-46E5945C9F61Q38981090-CDA79247-ED0A-4602-A0C2-7CC490CC58BCQ38996505-E74FC976-2617-438C-84C9-80B8AA0511ECQ41737427-83B9B067-FE70-40F6-B12D-3EA72FF40585Q42453484-8F76D8B1-395F-4D18-94FE-46BD72F93F38Q42476384-5BADDD71-50F3-44B6-BD4B-260E510FC546Q44876516-67FA29CD-EF83-4EAB-A652-9E8FD30372C4Q45249382-CD2C8EBD-0D12-4817-AED3-9C07825E5FE1Q46515365-E1301578-3592-4BAB-BD9F-CB28B897E660Q46883164-0FA0622F-86E8-482E-8AF0-CEA0FD5CE061Q47969669-9CB82C86-2BB6-4133-8612-AB958037D0E2Q50874704-23EB2AE9-6886-4AF1-893E-4551C3BBD0D5Q51145644-EB8C0674-69D9-4F04-A448-1DA1811B9E03Q51295354-7C8EF8BD-5652-4E0D-81E5-55A61125F780Q51582585-0ED114BD-C1E5-4D52-B119-BE0141C22D2AQ51769741-46441039-0296-457D-A4F7-9EC9735E7168Q52882844-87A95207-DF56-4BBC-B058-6850BAC91663Q58740177-172C9269-E969-46E8-820D-BFE51BD9BF03Q58825725-85D49703-27CD-463B-9753-B34F0FA12622Q83213614-86B2513D-29EE-47AC-9D09-795B012DE145Q84573852-FF28CB02-2A6C-483F-8C31-96EDD7258069Q86952977-5C6435A7-557D-43C8-A04C-3CF4E0684FCAQ87717593-308038AC-0F90-4176-96A6-324A76666DD3Q87722409-27A002BB-9EF8-45C5-802D-BBFA9E2EB2F9Q89027042-BF725F48-BABA-4E16-9230-D8018DD6C885Q93128560-408DE8F2-E99A-4890-8D96-DD8B602F1983Q93128568-CB9373FE-8898-4F71-9D99-C44BE47E2E2CQ93138027-3E7C3A41-8BB2-41CA-A80E-284EACFEFBA4
P50
description
researcher ORCID ID = 0000-0002-9081-0984
@en
name
Grzegorz Machnik
@ast
Grzegorz Machnik
@en
Grzegorz Machnik
@es
Grzegorz Machnik
@nl
type
label
Grzegorz Machnik
@ast
Grzegorz Machnik
@en
Grzegorz Machnik
@es
Grzegorz Machnik
@nl
prefLabel
Grzegorz Machnik
@ast
Grzegorz Machnik
@en
Grzegorz Machnik
@es
Grzegorz Machnik
@nl
P1153
10438911500
P31
P496
0000-0002-9081-0984